Search
×
FR

Placeholder headline

This is just a placeholder headline

API Technical Report TDB-6 Chapter 6 – Density

$

204

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 560: Fired Heaters for General Refinery Services

$

721

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 64: Diverter Equipment Systems

$

324

BUY NOW

Placeholder headline

This is just a placeholder headline

API MPMS CH 17.10.1: Refrigerated Light Hydrocarbon Fluids – Measurement of Cargoes on Board LNG Carries

$

417

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 13B-1: Testing Water-based Drilling Fluids

$

418

BUY NOW

Placeholder headline

This is just a placeholder headline

API Technical Report TDB-12 Chapter 12 – Thermal Conductivity

$

214

BUY NOW

Placeholder headline

This is just a placeholder headline

API 16FI Frac Iron Guidelines and Requirements

$

129

BUY NOW

ISO 12417:2022

ISO 12417:2022 Cardiovascular implants and extracorporeal systems – Vascular device-drug combination products – Part 2: Local regulatory information

CDN $273.00

SKU: 9757726a2a89 Category:

Description

This document provides region-specific information for:

-    local submissions and approvals for vascular device-drug combination products (VDDCPs) in countries and regions around the world;

-    changes related to the drug-containing part and how they are evaluated by different local regions.

For implanted products, this document is considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.

This document is considered also as a supplement to ISO 12417-1, and any relevant device-specific standards, such as the ISO 25539 series specifying requirements for endovascular devices. This document also addresses VDDCPs that are not necessarily permanent implants.

Edition

2

Published Date

2022-07-07

Status

PUBLISHED

Pages

29

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

This document provides region-specific information for:

-    local submissions and approvals for vascular device-drug combination products (VDDCPs) in countries and regions around the world;

-    changes related to the drug-containing part and how they are evaluated by different local regions.

For implanted products, this document is considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.

This document is considered also as a supplement to ISO 12417-1, and any relevant device-specific standards, such as the ISO 25539 series specifying requirements for endovascular devices. This document also addresses VDDCPs that are not necessarily permanent implants.

Previous Editions

Can’t find what you are looking for?

Please contact us at: